North Square Valuation

NMKYX Fund  USD 8.82  0.03  0.34%   
At this time, the fund appears to be overvalued. North Square Mckee secures a last-minute Real Value of $8.61 per share. The latest price of the fund is $8.82. We determine the value of North Square Mckee from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Overvalued
Today
8.82
Please note that North Square's price fluctuation is very steady at this time. At this time, the fund appears to be overvalued. North Square Mckee secures a last-minute Real Value of $8.61 per share. The latest price of the fund is $8.82. We determine the value of North Square Mckee from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Since North Square is currently traded on the exchange, buyers and sellers on that exchange determine the market value of North Mutual Fund. However, North Square's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  8.82 Real  8.61 Hype  8.82
The intrinsic value of North Square's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence North Square's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
8.61
Real Value
8.92
Upside
Estimating the potential upside or downside of North Square Mckee helps investors to forecast how North mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of North Square more accurately as focusing exclusively on North Square's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
8.518.829.13
Details

About North Square Valuation

Our relative valuation model uses a comparative analysis of North Square. We calculate exposure to North Square's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of North Square's related companies.
The fund invests at least 80 percent of its net assets in fixed and floating rate investment grade securities. The advisor focuses on investments in fixed maturity and callable U.S. government agency securities and high quality corporate bonds, agency mortgages and other investment grade securitized holdings, seeking to minimize the potential for loss of principal due to credit risk.

Other Information on Investing in North Mutual Fund

North Square financial ratios help investors to determine whether North Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in North with respect to the benefits of owning North Square security.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios